IGM Biosciences Stock (NASDAQ: IGMS) stock price, news, charts, stock research, profile.
Open | $9.280 |
Close | - |
Volume / Avg. | 27.926K / 290.810K |
Day Range | 9.201 - 9.630 |
52 Wk Range | 3.810 - 17.780 |
Market Cap | $560.236M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 41 |
Short Interest | 29.33% |
Days to Cover | 12.46 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of IGM Biosciences (NASDAQ: IGMS) through any online brokerage.
Other companies in IGM Biosciences’s space includes: Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Replimune Group (NASDAQ:REPL), Altimmune (NASDAQ:ALT) and CareDx (NASDAQ:CDNA).
The latest price target for IGM Biosciences (NASDAQ: IGMS) was reported by HC Wainwright & Co. on Tuesday, March 12, 2024. The analyst firm set a price target for 12.00 expecting IGMS to rise to within 12 months (a possible 25.92% upside). 26 analyst firms have reported ratings in the last year.
The stock price for IGM Biosciences (NASDAQ: IGMS) is $9.53 last updated Today at March 28, 2024 at 12:58 PM EDT.
There are no upcoming dividends for IGM Biosciences.
IGM Biosciences’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for IGM Biosciences.
IGM Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.